Compositions and methods for selective dissolution of nascent intravascular blood clots

Details for Australian Patent Application No. 2004255196 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Murciano, Juan Carlos; Cines, Douglas; Muzykantov, Vladimir R.

Agent FB Rice

Pub. Number AU-B-2004255196

PCT Pub. Number WO2005/004804

Priority 10/611,723 01.07.03 US

Filing date 28 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 8 October 2009

International Classifications

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/49 (2006.01) Medicinal preparations containing peptides

C12N 9/70 (2006.01) Enzymes, e.g. ligases (6.) - Streptokinase

C12N 9/72 (2006.01) Enzymes, e.g. ligases (6.) - Urokinase

C12N 9/96 (2006.01) Enzymes, e.g. ligases (6.) - Stabilising an enzyme by forming an adduct or a composition

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004804 Priority application(s): WO2005/004804

8 October 2009 Application Accepted

  Published as AU-B-2004255196

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255199-Coumarin derivatives for the treatment of ophthalmic disorders

2004255192-Billing system with authenticated wireless device transaction event data